Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6

  1. Wu, J.Y.
  2. Cock, H.R.
  3. Devinsky, O.
  4. Joshi, C.
  5. Miller, I.
  6. Roberts, C.M.
  7. Sanchez-Carpintero, R.
  8. Checketts, D.
  9. Sahebkar, F.
Journal:
Epilepsia

ISSN: 1528-1167 0013-9580

Year of publication: 2022

Volume: 63

Issue: 5

Pages: 1189-1199

Type: Article

DOI: 10.1111/EPI.17199 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals